查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829582

術中 MRI 市場（按場強、掃描儀類型、系統類型、應用和最終用戶）—2025-2032 年全球預測

Intraoperative MRI Market by Field Strength, Scanner Type, System Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，術中 MRI 市場將成長 48 億美元，複合年成長率為 12.59%。

主要市場統計數據
基準年2024年 18.6億美元
預計2025年 20.9億美元
預測年份：2032年 48億美元
複合年成長率（%） 12.59%

關於術中 MRI 的演變、臨床促進因素以及影響其在現代外科手術項目中應用的整合挑戰的權威概述

術中磁振造影(MRI) 已從一種新興的輔助手段發展成為重塑手術精準度和手術全期決策的重要工具。本介紹將闡述臨床、技術和組織促進因素如何融合，加速其在各專科實務中的應用。磁鐵設計、影像序列以及與外科工作流程整合的進步，使團隊能夠在維持功能的同時，確認手術切緣，最大限度地減少再次手術，並降低併發症發生率。同時，低場硬體、行動解決方案以及與手術器械相容性的提升，正在擴展可納入即時影像的手術範圍。

臨床醫生、醫院管理人員和設備規劃人員面臨更複雜的局面，需要協調臨床效果、營運約束和員工能力。報銷制度和實證前瞻性研究正在影響機構的投資意願，而技術供應商則以模組化系統和服務模式應對，這些模式強調工作流程的整合和培訓。因此，術中MRI的發展歷程是務實的創新。雖然這項技術正在逐漸成熟，成為能夠滿足臨床需求的實用解決方案，但成功的部署需要多學科協作、強力的變革管理以及明確的以患者為中心的價值衡量標準。

技術整合、工作流程整合和臨床證據正在推動術中 MRI 採用和實踐的根本性重塑。

由於技術創新、臨床證據的不斷累積以及醫療服務模式的不斷變化，術中 MRI 的前景正在改變。磁鐵工程和影像處理軟體的最新進展降低了術中應用的門檻，使得高保真、高場解決方案和靈活的低場系統能夠適應各種手術環境。同時，移動式和固定式系統設計的出現，使醫療機構能夠根據其手術量和機構限制調整資本投資。這些硬體創新與改進的成像序列和術中方案相輔相成，這些方案增強了組織對比度，減少了偽影，並縮短了採集時間，使術中 MRI 能夠更好地適應手術節奏。

不僅是硬體，以工作流程為中心的發展，例如與神經導航平台、設備追蹤技術和術中計劃工具的整合，正在將價值提案從單純的圖像採集轉變為全面的術中決策支援。同時，術中MRI的臨床證據也日益豐富，尤其是在神經外科腫瘤切除術以及整形外科和腫瘤科的應用領域。這些證據正在催生新的醫療途徑，優先考慮單階段確定性手術而非分階段介入。最後，供應商正在響應這一趨勢，推出強調培訓、遠端支援和結果監測的服務模式，進一步降低實施風險，並增強臨床醫生對術中MRI的信心。

2025 年美國關稅對術中 MRI 專案採購、供應鏈彈性和業務連續性的連鎖反應

隨著全球供應鏈和貿易政策的演變，美國將於2025年徵收關稅，已成為涉及術中成像解決方案的製造商、經銷商和醫療保健系統的關鍵因素。這些關稅措施對核心零件的採購計算產生了重大影響，這些零件通常在多個司法管轄區生產，例如超導性材料、專用梯度和某些電子子系統。為此，供應商不得不重新評估籌資策略，選擇替代供應商，在某些情況下，還要重新設計零件以減輕受影響關稅細則的影響。由於供應鏈被重新檢驗並實施雙重採購方案，這導致生產前置作業時間在短期內增加。

隨著資本採購週期調整以適應更長的前置作業時間和不斷變化的交貨計劃，臨床醫生和醫院採購團隊已經觀察到了下游影響。因此，醫療保健機構優先考慮策略採購計劃，並與供應商密切合作，以確保交付時間和透明的零件採購。同時，製造商盡可能加快本地化和國內組裝速度，以最大限度地降低關稅影響並提供更具彈性的交貨承諾。這些營運轉變也影響了服務合約和備件物流，迫使醫療保健系統重新評估生命週期支援協議，以確保護理的連續性，並最大限度地降低關鍵手術期間設備停機的風險。

細分級別的洞察揭示了場強、掃描器架構、系統移動性、臨床應用和最終用戶偏好如何決定技術選擇和臨床工作流程

對系統細分的細緻理解，有助於明確臨床需求與技術能力和採購偏好的交會點。低場平台佔地面積更小，屏蔽要求更簡單，並與現有手術室基礎設施的兼容性更高。封閉式設計與開孔設計會影響病患入路與術中人體工學。封閉式設計通常可為頭部和部分身體手術提供穩定的影像質量，而開孔設計則更易於手術入路和成像過程中的病患監測。

依系統類型進一步細分，可區分移動系統和固定系統，這是一個影響資本配置、房間轉換需求和調度靈活性的關鍵營運維度。對於希望在不改造永久病房的情況下將影像處理功能分配到多個病房的醫療機構而言，移動系統是一個相當有吸引力的選擇；而固定系統則通常被注重影像保真度和一體化手術室設計的高容量醫療中心所選擇。按應用領域分類，術中磁振造影 (MRI) 用於心血管外科、神經外科、腫瘤外科和整形外科手術，其中神經外科進一步分為開顱手術和脊椎外科，每種手術都反映了不同的影像處理和工作流程要求。最後，以最終用戶分類，門診手術中心和醫院的採用路徑不同：醫院通常會投資於支持複雜、多學科病例的綜合項目，而門診手術中心則更傾向於選擇經濟高效、精簡的系統，以適應高通量擇期手術。

亞太地區、歐洲和中東/非洲的區域動態和基礎設施現狀塑造了術中 MRI 的採用途徑和支持模式

區域動態對監管路徑、採購行為和臨床應用模式有重大影響。在美洲，成熟的神經外科專科中心和綜合醫療體係正在推動複雜腦腫瘤切除術和先進術中通訊協定的早期應用，這得益於密集的轉診網路和密集的研究活動。該地區對模組化服務結構和資金籌措模式的需求也十分強勁，這些模式旨在將資本投資與營運吞吐量和臨床結果預期相匹配。

在歐洲、中東和非洲，機構多樣性推動了多樣化的採用模式。先進的三級醫療中心追求高場強固定設備，以支援尖端的神經外科項目，而資源受限的中心則評估低場強或移動式方案，以平衡臨床效益與基礎設施和人員配備方面的考慮。監管協調和跨境臨床合作正在進一步影響採購決策週期和證據生成工作。在亞太地區，手術能力的快速擴張、醫院現代化程度的提高以及對專科護理的定向投資，正在推動人們對移動和固定解決方案的興趣，並重點關注擴充性、服務可靠性和本地支持網路。在全部區域，本地培訓計劃、報銷框架和供應鏈考量對於決定術中磁振造影的採用速度和形態至關重要。

競爭和服務促進因素再形成術中 MRI 生態系統中的供應商策略、整合模型和臨床夥伴關係

競爭格局由少數老牌製造商、新興專業供應商以及專注於整合、培訓和生命週期支援的服務供應商所構成。現有的技術供應商繼續利用其深厚的工程專業知識和臨床夥伴關係關係，提供全面的服務包，以擴展模組化、改進成像序列並降低部署和操作過程中的機構風險。同時，專業領域的參與企業則透過強調移動性、降低屏蔽要求和簡化使用者介面的設計選擇來脫穎而出，從而降低了手術室團隊將術中成像納入日常工作流程的門檻。

服務合作夥伴和系統整合商透過提供計劃管理、培訓和結果監控方案，將產品功能轉化為可靠的臨床表現，發揮日益重要的作用。供應商和臨床中心之間的合作促成了標準化協議和共用資料集的誕生，從而傳達了最佳實踐。保固和遠端支援模式也在不斷發展，以確保運作和快速解決問題。同時，規模較小的醫療機構更注重靈活性、整體擁有成本和供應商的應對力。這些趨勢凸顯了供應商需要將強大的技術產品與強大的商業性和臨床支援能力結合。

為醫療保健領導者提供可行的營運和策略建議，以最佳化術中 MRI 技術的選擇、實施、培訓和結果測量

產業領導者和醫院管理人員可以採取具體行動，確保術中MRI的成功部署並最大化臨床效益。首先，在計劃規劃初期協調臨床相關人員，明確病例組合、工作流程目標和培訓要求，確保技術選擇由手術需求而非供應商的說服力驅動。其次，優先制定籌資策略，該策略應包含生命週期支援、備件供應和明確的服務等級協議，以遵守手術計劃並確保可預測的正常執行時間。第三，考慮混合部署模式，將用於分散存取的行動系統與用於複雜病例的集中式固定單元相結合，從而最佳化資本配置和臨床覆蓋範圍。

第四，投資結構化培訓計畫和基於模擬的認證，以縮短臨床醫生的學習曲線，並將影像學通訊協定納入常規實踐。第五，建立一個結果監測框架，追蹤關鍵臨床指標，例如再次手術率、手術時間和以患者為中心的功能結果，並利用這些數據改進通訊協定，並證明持續投資的合理性。最後，與供應商保持密切合作，共同開發影像學方案、手術室人體工學以及與導航和手術計劃工具整合方面的漸進式改進，確保技術發展與臨床優先事項和操作限制緊密結合。

一種透明的、以證據為導向的研究途徑，整合臨床文獻、技術文件和相關人員訪談，為決策者提供可行的見解

本執行摘要所依據的研究綜合，是對同儕審查的臨床研究、技術白皮書、監管備案文件和供應商產品文件的結構化回顧，並輔以對臨床主任、採購專家和系統整合商的定性訪談。資訊經過跨多個獨立資訊來源的三角整合，以形成關於技術趨勢、應用促進因素和營運挑戰的連貫敘述。我們強調縱向臨床證據和實際實施經驗，以確保這些見解是基於實際實施的實際情況，而非行銷標語。

我們運用嚴謹的分析方法，解讀設備設計特性、工作流程影響和供應鏈漏洞，並關注各種用例，包括神經外科、腫瘤科、整形外科和心血管外科。我們仔細考慮了區域監管環境和採購慣例，並關注臨床有效性與操作可行性之間的相互作用。在直接比較資料有限的情況下，我們運用定性專家判斷來綜合評估專案結果的可能性，所有結論均優先考慮基礎假設和資料來源的可重複性和透明度。

綜合結論強調了成功的術中 MRI 計劃的臨床價值、實施要求和操作前提

總而言之，術中MRI在優先考慮單階段確定性介入措施和卓越組織保留結果的外科手術計畫中發揮著日益重要的作用。包括場強、掃描器架構和系統移動性等多功能性在內的技術創新，正在擴展術中成像實用且有益的臨床應用場景。同時，各關鍵專業領域日益成熟的證據正在明確術中MRI的臨床益處，促使更多醫療保健領導者將這種成像方式作為對卓越外科手術策略投資的一部分進行評估。

成功的實施不僅取決於設備性能；它需要臨床團隊、採購和服務合作夥伴的全面規劃，以及持續的培訓和結果評估。供應鏈和貿易政策的製定需要積極的採購規劃和強大的供應商夥伴關係關係，以確保服務的連續性。最終，那些能夠將臨床目標與技術選擇、訓練投資和結果監測巧妙地結合的機構，將最有能力將術中MRI功能轉化為對患者和系統可證明的價值。

目錄

第1章 引言

第2章分析方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將人工智慧整合到術中 MRI 工作流程中，實現即時影像分析
  • 開發7特斯拉超高磁場系統，提升手術精準度
  • 擴展我們用於門診和混合手術室的可攜式低場術中 MRI 設備產品組合
  • 影像設備製造商與機器人手術公司建立策略聯盟，共同打造整合式 iMRI 解決方案
  • 成本效率和工作流程最佳化在術中 MRI 採用和報銷模式中的重要性日益增加
  • 監管核准和安全指南推動新型術中 MRI造影劑和通訊協定的開發
  • 功能性神經外科中的新型術中 MRI 應用可實現大腦網路的即時映射

第6章：美國關稅的累積影響（2025年）

第7章：人工智慧（AI）的累積影響（2025年）

第 8 章術中 MRI 市場：依磁場強度

  • 高磁場
  • 低磁場

第9章：術中 MRI 市場（依掃描器類型）

  • 閉孔
  • 開膛

第 10 章。按系統類型分類的術中 MRI 市場

  • 可移動系統
  • 固定系統

第 11 章術中 MRI 市場：依應用

  • 心血管系統
  • 神經外科
    • 開顱手術
    • 脊椎手術
  • 瘤
    • 切片檢查指導
    • 腫瘤切除術
  • 整形外科

第 12 章術中 MRI 市場（依最終用戶分類）

  • 門診手術中心
  • 醫院

第13章 術中 MRI 市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章。按組別分類的術中 MRI 市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按國家/地區分類的術中 MRI 市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 市佔率分析（2024年）
  • FPNV定位矩陣（2024年）
  • 競爭分析
    • Siemens Healthineers AG
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Hitachi, Ltd.
    • Canon Medical Systems Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Neusoft Medical Systems Co., Ltd.
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • Samsung Electronics Co., Ltd.
Product Code: MRR-43539E5D2DD1

The Intraoperative MRI Market is projected to grow by USD 4.80 billion at a CAGR of 12.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.86 billion
Estimated Year [2025] USD 2.09 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 12.59%

An authoritative overview of intraoperative MRI evolution, clinical drivers, and integration challenges shaping adoption across modern surgical programs

Intraoperative magnetic resonance imaging has transitioned from a novel adjunct to an integral tool that reshapes surgical precision and perioperative decision-making. This introduction frames the clinical, technological, and organizational drivers that have converged to accelerate adoption across specialty practices. Advances in magnet design, imaging sequences, and integration with surgical workflows are enabling teams to verify resection margins, minimize repeat procedures, and reduce complication rates while preserving function. At the same time, improvements in low-field hardware, mobility solutions, and compatibility with operative instrumentation are widening the spectrum of procedures that can incorporate real-time imaging.

Clinicians, hospital administrators, and device planners are navigating a more complex landscape where clinical efficacy must align with operational constraints and staff competencies. Reimbursement pathways and evidence generation through prospective studies are shaping institutional willingness to invest, while technology vendors are responding with modular systems and service models that emphasize workflow integration and training. Consequently, the narrative of intraoperative MRI is one of pragmatic innovation: technologies are maturing into practical solutions that address demonstrated clinical needs, yet successful deployment requires multidisciplinary alignment, robust change management, and clear measures of patient-centered value.

How technological convergence, workflow integration, and clinical evidence formation are driving a fundamental reshaping of intraoperative MRI adoption and practice

The intraoperative MRI landscape is undergoing transformative shifts driven by converging technological innovation, evolving clinical evidence, and changes in care delivery models. Recent advances in magnet engineering and imaging software have reduced the barriers to intraoperative use, enabling both high-fidelity high-field solutions and flexible low-field systems that can be accommodated in a variety of operating environments. Simultaneously, the emergence of movable and stationary system designs has created options for institutions to align capital investment with procedural volumes and facility constraints. These hardware innovations are complemented by improved imaging sequences and intraoperative protocols that enhance tissue contrast, mitigate artifacts, and shorten acquisition times, thereby making intraoperative MRI more compatible with the tempo of surgery.

Beyond hardware, workflow-centric developments-such as integration with neuronavigation platforms, instrument-tracking technologies, and intraoperative planning tools-are shifting the value proposition from image acquisition alone to comprehensive intraoperative decision support. In parallel, the clinical evidence base for intraoperative MRI, particularly in neurosurgical tumor resection and select orthopedic and oncologic applications, is solidifying. This evidence is catalyzing new care pathways that prioritize single-stage definitive procedures over staged interventions. Finally, the vendor landscape is responding with service models emphasizing training, remote support, and outcome monitoring, which further lowers implementation risk and accelerates clinician confidence in intraoperative MRI.

The ripple effects of United States tariff measures in 2025 on procurement, supply chain resilience, and operational continuity for intraoperative MRI programs

As global supply chains and trade policies evolve, tariff dynamics introduced in the United States in 2025 have become a salient factor for manufacturers, distributors, and health systems involved with intraoperative imaging solutions. These tariff measures have materially affected the sourcing calculus for core components including superconducting materials, specialized gradients, and certain electronic subsystems that are often manufactured across multiple jurisdictions. In response, suppliers have had to reassess procurement strategies, qualify alternative vendors, and in some instances redesign components to mitigate exposure to affected tariff lines. This has resulted in near-term increases in production lead times as supply chains were revalidated and dual-sourcing options were operationalized.

Clinicians and hospital procurement teams have observed the downstream effects as capital procurement cycles adjusted to account for extended lead times and revised delivery schedules. Consequently, institutions have prioritized strategic procurement planning and closer collaboration with vendors to establish guaranteed delivery windows and transparent component sourcing. At the same time, manufacturers have accelerated regionalization and in-country assembly where feasible to minimize tariff sensitivity and provide more resilient delivery commitments. These operational shifts have implications for service contracts and spare-part logistics, prompting health systems to revisit lifecycle support agreements to ensure continuity of care and minimize the risk of equipment downtime during critical surgical periods.

Segment-level insights that reveal how field strength, scanner architecture, system mobility, clinical application, and end-user setting determine technology selection and clinical workflows

A nuanced understanding of system segmentation clarifies where clinical needs intersect with technological capabilities and procurement preferences. Based on Field Strength, systems fall into high-field and low-field categories, with high-field designs delivering higher intrinsic contrast and spatial resolution that benefit complex neurosurgical resections, while low-field platforms offer reduced footprint, simpler shielding requirements, and enhanced compatibility with existing operating room infrastructures. Based on Scanner Type, the distinction between closed bore and open bore systems influences patient access and intraoperative ergonomics, where closed bore units typically provide robust image quality for head and select body procedures and open bore designs facilitate surgical access and patient monitoring during imaging.

Further segmentation by System Type differentiates movable systems from stationary systems, an important operational axis that affects capital allocation, room conversion needs, and scheduling flexibility. Movable systems present a compelling choice for facilities seeking to distribute imaging capability across multiple suites without permanent room conversion, whereas stationary systems are often selected by high-volume centers prioritizing image fidelity and integrated OR design. Based on Application, intraoperative MRI is utilized across cardiovascular, neurosurgery, oncology, and orthopedic procedures, with neurosurgery further categorized into craniotomy and spinal surgery subtypes that reflect divergent imaging and workflow requirements; oncology applications are further distinguished between biopsy guidance and tumor resection, each demanding tailored imaging sequences and intraoperative decision protocols. Finally, based on End User, adoption pathways differ between ambulatory surgical centers and hospitals, with hospitals typically investing in integrated programs that support complex, multidisciplinary cases and ambulatory centers favoring cost-effective, streamlined systems suited to high-throughput elective procedures.

Regional dynamics and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways and support models for intraoperative MRI

Regional dynamics influence regulatory pathways, procurement behavior, and clinical adoption patterns in meaningful ways. In the Americas, established centers of neurosurgical excellence and integrated health systems have driven early adoption for complex brain tumor resections and advanced intraoperative protocols, supported by dense referral networks and concentrated research activity. This region also exhibits significant demand for modular service arrangements and financing models that align capital investment with operational throughput and clinical outcomes expectations.

In Europe, the Middle East & Africa, institutional diversity leads to heterogeneous adoption patterns: advanced tertiary centers pursue high-field stationary installations to support cutting-edge neurosurgical programs, while resource-constrained facilities assess lower-field or movable options to balance clinical benefits against infrastructure and staffing considerations. Regulatory harmonization and cross-border clinical collaborations further shape procurement decision cycles and evidence generation efforts. In the Asia-Pacific region, rapid expansion of surgical capacity, progressive hospital modernization, and targeted investments in specialty care drive interest in both movable and fixed solutions, with an emphasis on scalability, service reliability, and local support networks. Across these regions, localized training programs, reimbursement frameworks, and supply chain considerations are pivotal in determining the pace and shape of intraoperative MRI adoption.

Competitive and service-driven forces that are reshaping vendor strategies, integration models, and clinical partnerships in the intraoperative MRI ecosystem

The competitive landscape is defined by a small number of established manufacturers, emerging specialized vendors, and service providers focusing on integration, training, and lifecycle support. Established technology providers continue to leverage deep engineering expertise and clinical partnerships to extend modularity, improve imaging sequences, and offer comprehensive service packages that reduce institutional risk during deployment and operation. At the same time, specialist entrants are differentiating through design choices that emphasize mobility, reduced shielding requirements, and simplified user interfaces that lower the barrier for OR teams to adopt intraoperative imaging into routine workflows.

Service partners and systems integrators play an increasingly important role by offering project management, training, and outcome-monitoring programs that translate product capabilities into reliable clinical performance. Collaboration between vendors and clinical centers has produced standardized protocols and shared datasets that inform procedural best practices, while warranty and remote-support models are evolving to ensure uptime and rapid issue resolution. Importantly, procurement preferences reflect a balance between clinical ambition and operational pragmatism: high-volume centers prioritize image fidelity and throughput, whereas smaller facilities emphasize flexibility, total cost of ownership, and vendor responsiveness. These trends underscore the necessity for vendors to pair strong technical offerings with robust commercial and clinical support capabilities.

Actionable operational and strategic recommendations for healthcare leaders to optimize technology selection, deployment, training, and outcome measurement for intraoperative MRI

Industry leaders and hospital executives can take concrete actions to accelerate successful implementation and maximize clinical benefit from intraoperative MRI. First, align clinical stakeholders early in project planning to define case mix, workflow objectives, and training requirements so that technology selection is driven by procedural needs rather than vendor persuasion. Second, prioritize procurement strategies that incorporate lifecycle support, spare-part availability, and clearly defined service-level agreements to protect operative schedules and ensure predictable uptime. Third, consider hybrid deployment models that pair movable systems for distributed access with a centralized stationary unit for complex cases, thereby optimizing capital allocation and clinical coverage.

Fourth, invest in structured training programs and simulation-based credentialing to shorten the clinician learning curve and embed imaging protocols into routine practice. Fifth, establish outcome-monitoring frameworks that track key clinical indicators such as reoperation rates, procedure times, and patient-centered functional outcomes, and use those data to refine protocols and justify continued investment. Finally, maintain close collaboration with vendors to co-develop incremental improvements in imaging protocols, OR ergonomics, and integration with navigation and surgical planning tools, ensuring that technology evolution remains tightly coupled to clinical priorities and operational constraints.

A transparent, evidence-focused research approach integrating clinical literature, technical documentation, and stakeholder interviews to produce actionable insights for decision-makers

The research synthesis underpinning this executive summary combines a structured review of peer-reviewed clinical studies, technical white papers, regulatory filings, and vendor product documentation, complemented by qualitative interviews with clinical leads, procurement specialists, and systems integrators. Information was triangulated across multiple independent sources to develop a coherent narrative of technological trends, adoption drivers, and operational challenges. Emphasis was placed on longitudinal clinical evidence and real-world deployment experiences to ensure that insights are grounded in practical implementation realities rather than promotional statements.

Analytical rigor was applied to interpret device design attributes, workflow implications, and supply-chain vulnerabilities, with attention to variant use-cases across neurosurgery, oncology, orthopedics, and cardiovascular applications. Careful consideration was given to regional regulatory contexts and procurement practices, and sensitivity was maintained to the interplay between clinical efficacy and operational feasibility. Where direct comparative data were limited, qualitative expert judgment was used to synthesize likely programmatic outcomes, and all conclusions prioritize reproducibility and transparency in the underlying assumptions and data sources.

Synthesized conclusions highlighting the clinical value, implementation imperatives, and operational prerequisites for successful intraoperative MRI programs

In conclusion, intraoperative MRI occupies an increasingly central role in surgical programs that prioritize single-stage definitive interventions and superior tissue-sparing outcomes. Technological innovations in field strength versatility, scanner architecture, and system mobility have expanded the set of clinical settings where intraoperative imaging is practical and beneficial. At the same time, evidence maturation in key specialties has clarified where intraoperative MRI delivers measurable clinical benefits, prompting more healthcare leaders to evaluate this modality as part of strategic investments in surgical excellence.

Implementation success depends on more than device performance: it requires integrated planning across clinical teams, procurement, and service partners, as well as ongoing training and outcome measurement. Supply-chain and trade policy developments necessitate proactive procurement planning and robust vendor partnerships to ensure continuity of service. Ultimately, institutions that thoughtfully align clinical objectives with technology selection, training investments, and outcome monitoring will be best positioned to convert intraoperative MRI capability into demonstrable patient and system value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence driven real time image analysis in intraoperative MRI workflows
  • 5.2. Development of ultra high field 7 Tesla intraoperative MRI systems for improved surgical precision
  • 5.3. Expansion of portable low field intraoperative MRI units for outpatient and hybrid operating rooms
  • 5.4. Strategic collaborations between imaging device manufacturers and robotic surgery companies for integrated iMRI solutions
  • 5.5. Rising emphasis on cost effectiveness and workflow optimization in intraoperative MRI adoption and reimbursement models
  • 5.6. Regulatory approvals and safety guidelines shaping the development of novel intraoperative MRI contrast agents and protocols
  • 5.7. Emerging intraoperative MRI applications in functional neurosurgery enabling real time mapping of brain networks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative MRI Market, by Field Strength

  • 8.1. High Field
  • 8.2. Low Field

9. Intraoperative MRI Market, by Scanner Type

  • 9.1. Closed Bore
  • 9.2. Open Bore

10. Intraoperative MRI Market, by System Type

  • 10.1. Movable Systems
  • 10.2. Stationary Systems

11. Intraoperative MRI Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Neurosurgery
    • 11.2.1. Craniotomy
    • 11.2.2. Spinal Surgery
  • 11.3. Oncology
    • 11.3.1. Biopsy Guidance
    • 11.3.2. Tumor Resection
  • 11.4. Orthopedic

12. Intraoperative MRI Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Intraoperative MRI Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intraoperative MRI Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intraoperative MRI Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Siemens Healthineers AG
    • 16.3.2. GE HealthCare Technologies Inc.
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Hitachi, Ltd.
    • 16.3.5. Canon Medical Systems Corporation
    • 16.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 16.3.7. Neusoft Medical Systems Co., Ltd.
    • 16.3.8. Esaote S.p.A.
    • 16.3.9. FUJIFILM Holdings Corporation
    • 16.3.10. Samsung Electronics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. INTRAOPERATIVE MRI MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. INTRAOPERATIVE MRI MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE MRI MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GCC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 266. GCC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 267. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. GCC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 275. GCC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. GCC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. GCC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GCC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. G7 INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 314. G7 INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 315. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. G7 INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. G7 INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. G7 INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 322. G7 INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 323. G7 INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 324. G7 INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 325. G7 INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. G7 INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 328. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 329. NATO INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 330. NATO INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 331. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. NATO INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 336. NATO INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 337. NATO INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 338. NATO INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 339. NATO INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. NATO INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 341. NATO INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. NATO INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 344. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 345. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)